Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Residual Content of TWIRLA Transdermal System
NCT07739589Phase 4Completed
- Sponsor
- Insud Pharma
- Start
- Oct 2021
- Primary completion
- Nov 2021
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ethinylestradiol + levonorgestrel in pregnancy, sponsored by Insud Pharma. Primary endpoints: The Sum of Means for EE and LNG Content on Used TDSs, Storage Pouches, Release Liners, and Skin Swabs at 7 days and The Sum and Means for EE and LNG Content on Control TDSs, Storage Pouches, and Release Liners at 7 days. Started Oct 2021; status: completed.
02
Drugs
ethinylestradiol + levonorgestrel
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT07739589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07739589.